ukmla MCQ (SBA): NSTEMI Secondary Prevention

Instant feedback + full explanation. One question, done properly.

MediumCardiologyNSTEMI Secondary Preventionukmlamrcp part 1mrcgp aktmrcem sbaprescribing safety assessment

A 68-year-old man with NSTEMI treated conservatively is being discharged. Which dual antiplatelet duration is recommended, assuming no high bleeding risk?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: NSTEMI Secondary Prevention — Answer & Explanation | iatroX